IPHA short interest
Innate Pharma S.A. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 88,622 |
|---|---|
| Change vs prior report | 12,549 (+16.5%) |
| Change over six months | +24.4% |
| Days to cover | 1.25 (sector: 3.78) |
| Average daily volume | 71,100 |
| Rank in Healthcare | #756 of 922 by days to cover |
IPHA short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 88,622 | +16.5% | 1.25 | 71,100 |
| 2026-09-15 | 76,073 | -7.2% | 4.09 | 18,580 |
| 2026-08-31 | 81,961 | -63.9% | 1.81 | 45,216 |
| 2026-08-14 | 227,041 | +49.0% | 1.00 | 721,354 |
| 2026-07-31 | 152,432 | -6.8% | 27.54 | 5,534 |
| 2026-07-15 | 163,552 | -9.1% | 22.81 | 7,171 |
| 2026-06-30 | 179,942 | -14.0% | 14.56 | 12,356 |
| 2026-06-15 | 209,331 | +8.0% | 3.45 | 60,643 |
| 2026-05-29 | 193,882 | -21.1% | 5.02 | 38,620 |
| 2026-05-15 | 245,729 | +171.5% | 1.04 | 236,746 |
| 2026-04-30 | 90,515 | +41.0% | 3.86 | 23,442 |
| 2026-04-15 | 64,220 | -9.9% | 2.28 | 28,152 |
| 2026-03-31 | 71,264 | -6.5% | 3.13 | 22,775 |
| 2026-03-13 | 76,183 | -23.2% | 4.42 | 17,232 |
| 2026-02-27 | 99,192 | -21.0% | 7.28 | 13,625 |
| 2026-02-13 | 125,617 | -40.3% | 6.04 | 20,805 |
| 2026-01-30 | 210,405 | -7.5% | 8.29 | 25,379 |
| 2026-01-15 | 227,571 | -6.1% | 15.18 | 14,987 |
| 2025-12-31 | 242,455 | +0.6% | 6.62 | 36,643 |
| 2025-12-15 | 241,070 | -0.3% | 15.02 | 16,050 |
| 2025-11-28 | 241,759 | +9.4% | 9.51 | 25,417 |
| 2025-11-14 | 220,987 | +281.7% | 1.00 | 984,267 |
| 2025-10-31 | 57,894 | +9.1% | 1.82 | 31,885 |
| 2025-10-15 | 53,076 | +9.0% | 4.19 | 12,675 |
| 2025-09-30 | 48,691 | +5.0% | 1.72 | 28,356 |
import finzdata as yf
yf.Ticker("IPHA").short_interest # every report since 2017
yf.Client().short_interest(["IPHA"], start="2018-01-01")Healthcare short interest · IPHA price history · Who owns IPHA · All short interest